- Posted January 2, 2013 by
MarginProbe Receives FDA Approval
Dune Medical Devices, Inc., announced today that its breakthrough intra-operative tissue assessment tool for early-stage breast cancer surgery, the MarginProbe System, has received Premarket Approval (PMA) by the United States Food and Drug Administration. The technology significantly improves surgeons’ ability to intra-operatively identify "cancer on the margin” and significantly reduce pathologically positive margins following a patient’s initial lumpectomy surgery.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58891-dune-medical-devices-fda-approval-marginprobe-system-breast-cancer-surgery